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Abstract. Background/Aim: Synovial sarcoma is a soft
tissue sarcoma that tends to affect young adults. There are
few reports on primary synovial sarcoma of the thyroid and
the aim of this study was to document the clinical and
pathological features of synovial sarcoma occurring at this
site. Case Presentation: A retrospective review of a
prospectively maintained database was performed to identify
patients with synovial sarcoma of the thyroid treated at the
Royal Marsden Hospital between 2000 and 2017. Five
patients were identified that underwent initial surgical
management of localized disease. The mean age at
presentation was 38 years, and male to female ratio was 4:1.
In 3 out of 5 cases, the diagnosis of synovial sarcoma was
made on the post-operative excision specimen. Two of these
patients were treated at our institution on the development of
metastatic disease. We conducted a literature review and
identified 12 previously reported cases of synovial sarcoma
of the thyroid. Conclusion: Synovial sarcoma of the thyroid
is rare and can be challenging to diagnose. The clinical
presentation is typically indistinguishable from that of thyroid
cancer and most cases are diagnosed post-operatively on an
excision specimen. The clinical and pathological features are
similar to synovial sarcoma arising at other sites. In our
experience, the rarity of the diagnosis can lead to difficulty
in establishing the correct diagnosis and determining the
appropriate treatment pathway. It is important that physicians
are aware of this diagnosis to facilitate prompt referral to a
specialist centre, for specialist follow-up and treatment which
is different to the thyroid cancer pathway. 
Soft tissue sarcomas are solid tumours of mesenchymal
origin, comprising over 50 different histological subtypes.
Synovial sarcoma comprises about 5% of all soft tissue
sarcomas, and is a malignant mesenchymal neoplasm
showing partial epithelial differentiation, which is
characterized by a specific t(X;18)(p11.2;q11.2) translocation
leading to generation of SYT-SSX fusion gene transcripts (1).
The median age of diagnosis of synovial sarcoma is in the
late thirties, and over 65% of these tumours occur in the
extremities, particularly the lower limbs (2). However, it has
been shown to arise at almost any anatomic location,
including viscera, and approximately 10% affect the head
and neck region (1, 2). The thyroid is an exceptionally rare
site, and to our knowledge there have only been 12 reported
cases of synovial sarcoma of the thyroid gland in the
literature (3-13).
The diagnosis of synovial sarcoma of the thyroid gland
is challenging and may be delayed as the established
diagnostic pathway for evaluation of focal thyroid nodules
includes ultrasound with fine needle aspiration of equivocal
lesions. Although this is usually sufficient for diagnosis of
the more common thyroid pathologies, a diagnosis of
sarcoma is challenging using cytology alone. Ideally if a
diagnosis of sarcoma is suspected, core needle biopsy
should be carefully planned and performed by a specialist
to enable the biopsy tract to be excised subsequently during
definitive surgery (14). However, as a rare diagnosis
without specific imaging features, synovial sarcoma of the
thyroid is rarely suspected. Polymerase chain reaction
(PCR) or fluorescent in situ hybridization (FISH) can
identify the characteristic chromosomal translocation
(X;18), which is the most definitive molecular diagnostic
test for synovial sarcoma. This translocation is present in
over 90% of synovial sarcomas (1). Staging should include
magnetic resonance imaging (MRI) of the neck for local
staging and contrast enhanced computed tomography (CT)
of the thorax, abdomen and pelvis to determine the
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presence of distant metastases (14). The commonest site for
metastatic disease is the lung (15). Equivocal lesions can
be further characterized by targeted US +/– sampling or
FDG PET/CT.
The management of localized synovial sarcoma consists
of surgery with or without radiation. The role of
chemotherapy in the management of localized synovial
sarcoma of any location remains controversial as it is
indicated by a number of conflicting retrospective studies
(16-18). In the metastatic setting, synovial sarcoma is
considered a relatively chemosensitive subtype, with
responses being observed particularly to ifosfamide based
schedules (19-22). The aim of this study was to report our
single-centre experience of the diagnostic trajectory and the
clinical management of synovial sarcoma affecting the
thyroid gland. 
Materials and Methods
Institutional approval was obtained prior to commencing the study.
We performed a retrospective search of a prospectively maintained
database to identify patients with synovial sarcoma of the thyroid
gland treated at the Royal Marsden between 2000 and 2017.
Demographic, treatment and follow-up data were obtained from the
electronic patient record. Chemotherapy for metastatic disease was
administered using standard protocols with re-imaging performed
after two cycles of therapy. Response was assessed using Response
Evaluation Criteria in Solid Tumours (RECIST) 1.1. Descriptive
statistics were employed.
The pathological diagnosis of synovial sarcoma was confirmed
in all cases by two experienced soft tissue sarcoma pathologists
(KT, CF). Molecular, genetic and cytogenetic analyses were
performed on formalin-fixed, paraffin embedded (FFPE) material,
for SS18 gene rearrangements by FISH or for SS18-SSX1 or SS18-
SSX2 fusion transcripts by reverse transcription-polymerase chain
reaction (RT-PCR). For FISH, 2-4 μm thick FFPE sections were
dewaxed overnight at 60˚C, treated with wash buffer at 80˚C (2-3
h), incubated with proteolytic enzymes at 37˚C, and washed in
distilled water followed by an alcohol wash series before addition
of SS18 DNA probes (Vysis, Abbott Laboratories Ltd, Maidenhead,
UK). Hybridization was performed overnight according to
manufacturer’s protocols. RT-PCR was performed according to
standard, previously described methods (23). 
Results
Five patients with synovial sarcoma of the thyroid gland
were identified. Two of these patients were treated at the
Royal Marsden Hospital. Both these male patients were
treated with thyroidectomy at other hospitals under the local
head and neck units, and one received post-operative
radiation. 
Case 1. The first patient, aged 37 years, presented with
thyroid synovial sarcoma and was treated with
thyroidectomy and post-operative radiotherapy at another
hospital. He had no past medical history of note. Excision
margins were clear and there was no distant metastatic disease
at initial presentation. Whilst on follow-up, eight years later,
he developed chest pain and haemoptysis, due to extensive
chest wall, mediastinal and pulmonary metastatic disease. 
De-bulking surgery was undertaken bronchoscopically.
Histopathology confirmed metastatic synovial sarcoma, and
showed a relatively circumscribed cellular neoplasm, which
entrapped lung parenchyma and was composed of elongated
slender spindle cells with minimal pleomorphism and mitotic
activity. Thyroid synovial sarcoma showed nuclear
expression of TLE1 with focal bcl-2 positivity, but was
negative for cytokeratins MNF116, AE1/AE3, and epithelial
membrane antigen (EMA), S100 protein, CD34, TTF-1,
CD99, WT1, SMA, desmin, MUC4, CD31, CD117, DOG1,
EBER, STAT6, HHV8 and calretinin. FISH showed SS18
gene rearrangement, confirming the diagnosis. He was
subsequently referred to the Royal Marsden Hospital, and
repeat CT imaging showed a mediastinal and a left lower
lobe lung metastasis. In view of the macroscopic metastatic
disease, he was treated with doxorubicin and ifosfamide with
subsequent disease regression. He tolerated combination
chemotherapy well. Consolidation radiation comprising
50.4Gy in 28 fractions was administered to the dominant site
of disease recurrence in the left thorax followed by
radiofrequency ablation to the distal left lower lobe lung
lesion. In December 2015, after a follow-up period of 14
months without treatment, there was evidence of multi-focal
disease progression in the lungs. He was commenced on
second-line chemotherapy consisting of an infusional
ifosfamide schedule (1 g/m2 ifosfamide per day for 14 days
of a 28-day cycle). The disease responded to ifosfamide and
he received eight cycles in total but demonstrated
progressive disease soon after. He commenced trabectedin
two months later and received 4 cycles, but repeat imaging
demonstrated progressive disease. He finally died 30 months
following the diagnosis of metastatic disease.
Case 2. The second patient was a 47-year-old male who
initially presented in 2013, when he noticed a left-sided
thyroid nodule. At presentation, he was clinically well and
asymptomatic. Past medical history included hypertension
and hypercholesterolaemia, psoriasis with arthropathy, and a
spontaneous pneumothorax at the age of 18 years old. He
was a lifelong non-smoker. A core biopsy was performed at
the local hospital, but the diagnosis was not established. A
CT-positron emission tomography (PET) scan showed no
distant sites of metastatic disease. A total thyroidectomy and
bilateral lymph node dissection was subsequently performed
at another hospital. The histopathology of the surgical
specimen noted inflammatory cells, with the possibility of
microscopic residual tumour cells. Lymph nodes were clear
of metastatic disease. Review of the core biopsy at the Royal
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Marsden established that the tumour showed the biphasic
pattern of synovial sarcoma, with fascicles of minimally
atypical spindle cells with intermixed islands of epithelioid
cells, sometimes forming a vague glandular pattern. Mitotic
figures were prominent. Immunohistochemistry showed
diffuse expression of CD56 and diffuse nuclear expression
of TLE1, but no expression of cytokeratins or EMA. FISH
showed SS18 gene rearrangement, and SS18-SSX2 fusion
transcripts were detected by RT-PCR, confirming synovial
sarcoma. 
Following this pathology review, the patient was
referred to our centre two years after initial diagnosis for
surveillance. During this period, he was treated for
persistent symptomatic hypocalcemia in the context of
post-operative hypoparathyroidism, but was otherwise well
and was not followed-up for his synovial sarcoma prior to
being referred to the Royal Marsden. On assessment at our
centre he was asymptomatic, however the chest radiograph
showed multifocal pulmonary metastatic disease. As there
was no suspicion on other primary tumors we concluded
that he had metastases of his previous thyroidal synovial
sarcoma. It was decided to start combination therapy with
doxorubicin and ifosfamide to increase the chance of a
volume response enabling subsequent local treatment of
his metastases. He achieved a response to therapy and
tolerated combination chemotherapy well. One of the
metastatic lesions showed initial cavitation (Figure 1)
followed by dimensional shrinkage amounting to a partial
response following six cycles of chemotherapy. Cavitation
can occur in metastatic soft tissue sarcoma including
synovial sarcoma (24, 25). Following chemotherapy he
underwent resection of the two right lung metastases
followed by left thoracotomy and resection of a left upper
lobe metastasis. Pathology from both surgical procedures
confirmed the presence of metastatic synovial sarcoma.
Due to pleural involvement of the left lung metastasis he
was treated with post-operative radiation to the left upper
lung. He subsequently developed recurrent disease in the
left lung 11 months later. He was treated with 4 cycles of
trabectedin and further surgery. Following this he was
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Figure 1. Response of lung metastases to chemotherapy. CT lung image of a 47-year old patient with previous history of synovial sarcoma who
presented with multifocal pulmonary metastases. As shown in this image one of the metastatic lesions showed initial cavitation followed by
dimensional shrinkage amounting to a partial response following six cycles of chemotherapy.
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Table I. Literature review of previously reported cases of thyroid synovial sarcoma.
Author/     Age/         Presenting        Subtype        Size,             Imaging             Mets at          Management           Follow-up,    Time to     Time to 
date          gender        complaint                                cm          characteristics     presentation                                             mo              mets,         death, 
                                                                                                                                                                                                                    mo              mo
Roth,        15/M     Earache when    Biphasic        Not                None                   No                     Total                      144               N/a           Alive 
1975                          swallowing,                        recorded          recorded                                   thyroidectomy                                                     at f/u
                                   excessive                                                                                                       and cobalt 
                                   salivation                                                                                                          therapy
Kikuchi,   60/M       Hoarseness,      Biphasic     6.8×6.5         CT showed              No                     Total                        32                 18               32
2003                             palpable                                              thyroid tumour                             thyroidectomy 
                                     tumour                                               with destruction                               with partial
                                                                                                     of thyroid/                                   resection of 
                                                                                                cricoid cartilage                               thyroid and 
                                                                                                                                                      cricoid cartilage, 
                                                                                                                                                      partial resection 
                                                                                                                                                        of the cervical 
                                                                                                                                                      oesophagus and 
                                                                                                                                                          lymph node 
                                                                                                                                                           dissection
Jang,        15/M          Palpable         Biphasic      6×5×5         CT showed              No                     Total                      Not              Not            Not 
2007                           neck mass                                            well-demarcated                            thyroidectomy           recorded      recorded     recorded
                                                                                                   solid mass at                                    and left 
                                                                                                the superior and                                  cervical 
                                                                                                  lateral portion                              LN dissection
                                                                                                     of the left 
                                                                                                  thyroid gland
Harb,         Not               Not                 Not            Not                 Not                    Not                     Not                        Not              Not            Not 
2007       recorded       recorded         recorded    recorded          recorded             recorded             recorded                recorded      recorded     recorded
Ryu,          72/F        Hoarseness,   Monophasic  6×5×4.5    Ultrasonography          Yes                    Total                         2                   0                 2
2011                           dysphagia,                                                   showed                                    thyroidectomy 
                                   neck mass                                            heterogeneously                              with tracheal                   
                                                                                                    hypoechoic                                   fenestration                     
                                                                                                   nodule with 
                                                                                                   calcification.
                                                                                                    CT showed 
                                                                                                    large, low-
                                                                                                    attenuating
                                                                                                         mass
Ghafouri   44/F           Rapidly-           Mono-      17×14×6       CT showed              No                Incomplete                 Not              Not            Not 
2013                             growing           phasic                           large tumour                                    excision                recorded      recorded     recorded
                                   neck mass                                               with tracheal 
                                                                                                      deviation
Boudin,    55/M          Rapidly-           Mono-          7×7       Ultrasonography          No            Thyroidectomy               10                Not           Alive 
2014                             growing           phasic                               showed                                  with incomplete                              recorded       at f/u
                                   neck mass                                              heterogenous,                                   excision, 
                                                                                              hypervascularized,                         chemoradiation, 
                                                                                                    mixed solid                                   re-excision
                                                                                                and liquid mass
Crowson    Not               Not                 Not            Not                 Not                    Not                     Not                        Not              Not            Not 
2015a       recorded       recorded         recorded    recorded          recorded             recorded             recorded                recorded      recorded     recorded
Crowson    Not                Not                  Not             Not                  Not                     Not                     Not                        Not               Not             Not
2015a     recorded       recorded         recorded    recorded          recorded             recorded             recorded                recorded      recorded     recorded
Bansal,     28/F           Rapidly-             Not        9.5×12.5        CT showed              No                     Total                      Not              N/a           Alive 
2015                          progressive      recorded                      heterogeneously-                            thyroidectomy          specified                            at f/u
                                       neck                                                     enhancing                                 with resection 
                                    swelling,                                                  solid cystic                                of retrosternal 
                                  dysphagia,                                                lesion with                                   tumour and 
                                     weight                                                    peripheral                                      adjuvant 
                                        loss                                                     calcification                                  radiotherapy
Table I. Continued
treated with 6 months of pazopanib and his disease
progressed rapidly. He deceased 31 months from diagnosis
of metastatic disease. 
Case 3. The third patient was a 42-year-old male, who had
had a neck mass excised in 1997, which had been diagnosed
elsewhere as paraganglioma. The patient developed locally
recurrent disease and was referred to our institution for re-
excision four years later. Grossly this comprised of thyroid
tissue containing a 3.5 cm nodular lesion. Histology showed
fibrous tissue and skeletal muscle containing cellular tumour
composed of fascicles of minimally to mildly spindle cells
with elongated or ovoid nuclei, indistinct nucleoli and
scanty cytoplasm, and a mitotic index of up to 16/10 hpf.
While no epithelial elements were discernible
morphologically, reticulin staining showed a vaguely
packeted arrangement of tumour cells. The tumour showed
strong focal expression of EMA and bcl-2, with focal S100
protein, but was negative for MNF116, CAM5.2, CK903,
CD99, CD34, CD117, SMA, HMB45, CD31, desmin and
neurofilament. The tumour was present at the surgical
margin. FISH showed SS18 gene rearrangement, confirming
synovial sarcoma. The patient was found approximately one
year later to have multiple lung metastases, two of which
were excised, with histology confirming metastatic synovial
sarcoma. The patient received conventional chemotherapy
elsewhere with a good response but had no further follow-
up at our institution. 
Case 4. The fourth patient was a 36-year-old man who
noticed a lump on his neck in July 2017, that was not fully
investigated until August 2017, when he had a biopsy.
Subsequent to this, he was lost to follow-up from the
referring clinic. A biopsy that was taken was reviewed locally,
but also seen at the RMH, and the diagnosis was confirmed
as synovial sarcoma. These studies have shown evidence of
a translocation involving the SS18 gene at 18 q 11.2. A
staging CT scan on the 1st December 2017, showed a large
mass in the right lobe of the thyroid gland (5.7×7.5 cm in the
axal plane and craniocaudal, up to 9 cm) as well as numerous
lung nodules consistent with metastases. Due to his
symptoms of shortness of breath and difficulty in swallowing,
he was referred to the Royal Marsden. Due to the size and
anatomic location of the tumour, it was deemed not
resectable. He was commenced on combination doxorubicin
and ifosfamide. His symptoms were improved and according
to RECIST criteria the disease was radiologically stabilised.
Subsequently he was treated with radiation and an ATR
inhibitor within a clinical trial. He has recently completed
radiation and is well. 
Case 5. The fifth patient was a 30-year-old female with a
tumour in the right thyroid lobe which involved adjacent
structures in the neck. This patient was referred to our
institution for pathology review alone. The excision
specimen showed a cellular tumour, composed of sheets of
relatively monotonous, mildly atypical rounded to ovoid
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Table I. Continued
Author/     Age/         Presenting        Subtype        Size,             Imaging             Mets at          Management           Follow-up,    Time to     Time to 
date          gender        complaint                                cm          characteristics     presentation                                             mo              mets,         death, 
                                                                                                                                                                                                                    mo              mo
Murro,      41/M        Dysphonia       Biphasic        Not                None                   No                     Total                        13                N/a           Alive 
2015                             and left                            recorded          recorded                                   thyroidectomy                                                     at f/u
                                   neck mass                                                                                                   and subsequent 
                                                                                                                                                          laryngopha-
                                                                                                                                                           ryngoeso-
                                                                                                                                                         phagectomyb
Shi,           31/M            Large           Biphasic      5×2×2     Ultrasonography           No                     Total                        34                 24            Alive 
2016                        asymptomatic                                                showed                                   thyroidectomy                                                     at f/u
                                       mass                                                   heterogenous,                                      with 
                                                                                                 hypervascular,                                incomplete                                         
                                                                                                     solid mass                                      excision. 
                                                                                                                                                       Chemotherapy 
                                                                                                                                                             and LN 
                                                                                                                                                           dissection 
                                                                                                                                                            at relapse
aCrowson et al. reported 2 cases of thyroid synovial sarcoma within a study of synovial sarcomas of the head and neck; bAt initial operation, tumour
was found to be arising from tracheoesophageal groove with direct extension into thyroid, trachea and oesophagus; Mo: months; F: female; M:
male; CT: computed tomography; F/u: follow-up; Mets: metastases; LN: Lymph node. 
cells with vesicular nuclei and scanty cytoplasm. The tumour
was diffusely positive for CD56 and focally positive for
cytokeratins and EMA, and a nested pattern was seen with
reticulin stain. The features were consistent with poorly
differentiated synovial sarcoma. 
Discussion and Conclusion
Synovial sarcoma of the thyroid gland is an extremely rare
condition, with only 12 published cases, four of which are
reported within published series of synovial sarcomas of the
head and neck (3-13). These include one report of thyroid
involvement arising by direct extension of a primary synovial
sarcoma in the tracheoesophageal groove, which was treated
surgically (12). The published reported cases of synovial
sarcoma arising in the thyroid are summarised in Table I. Our
review of thyroid synovial sarcoma referred to the Royal
Marsden since 2000 identified five patients, highlighting that
this is an extremely rare diagnosis. The mean age of patients
in our study was 38 (range=30-47 years), similar to the mean
age of patients in previously reported cases, that was 40. In
all cases there was a higher frequency in males with a ratio
of 4:1 in our study. The incidence of synovial sarcoma in any
anatomic site is reported to be slightly higher in males than
females. The rarity of the tumour in the thyroid gland makes
it an unexpected clinical and pathological finding in practice,
which can be challenging to diagnose. Synovial sarcoma is
itself a rare subtype comprising about 5% of soft tissue
sarcomas, with an incidence of 1-3 cases per million, and 81
new cases in the UK in 2010 (26). Both anaplastic and
medullary thyroid carcinoma are rare. These are the two
rarest subtypes of thyroid cancer, each comprising about 3%
of thyroid cancer cases. The incidence of thyroid cancer in
the UK is 3.0 per 100,000 men and 7.4 per 100,000 women,
with follicular thyroid cancer being the most common
subtype (27). Typically, there are 70-90 new cases of
anaplastic carcinoma each year in the UK (28). Synovial
sarcoma of the thyroid gland typically presents with a neck
mass, which may be rapidly progressive, and there may be
associated symptoms such as hoarseness of voice or
dysphagia. In our experience, the clinical presentation can be
indistinguishable from that of thyroid cancer. Histologically,
synovial sarcomas can be purely spindle cell neoplasms
(monophasic variant), mixed spindle and epithelioid cell
neoplasms (with glandular or other epithelial structures in
varying degrees of differentiation) (biphasic type) or round
cell tumours (poorly differentiated type), with focal
cytokeratin and EMA expression and often CD56 expression
(1). These can therefore easily be mistaken for poorly
differentiated, sarcomatoid or neuroendocrine carcinomas.
Pre-operative fine needle aspiration cytology (FNAC) was
described in five of the previously reported cases of thyroid
synovial sarcoma. In four of these (3, 5, 11, 12) the
impression following FNAC was of medullary or
dedifferentiated/anaplastic thyroid carcinoma, and in the fifth
case the specimen was regarded as a benign follicular lesion
(4). In all previously reported cases, the diagnosis of synovial
sarcoma was made post-operatively, on an excision specimen.
We report a similar experience here, where 3 out of 5 cases
referred to our centre were diagnosed on post-operative
excision specimens. One patient underwent core biopsy prior
to surgery, which was identified as synovial sarcoma on
review by a sarcoma pathology specialist at our centre.
The initial diagnostic investigation of choice in suspected
thyroid cancer is ultrasound-guided fine needle aspiration
cytology (FNAC). The diagnosis of thyroid malignancy
cannot always be made on FNAC alone, and in such cases
the patient may undergo diagnostic surgery (29). In all
reported instances, the diagnosis of synovial sarcoma of the
thyroid was not established by FNAC. The cytology is more
likely to be interpreted as suggestive of medullary or
anaplastic carcinoma, in keeping with observed cytological
similarities. On imaging, necrosis which is often encountered
in synovial sarcomas could be mistaken for cystic change in
benign thyroid nodules (15), and calcifications are
encountered in common thyroid pathologies and synovial
sarcoma. Therefore, core needle biopsy should be considered
following inconclusive ultrasound and cytology of a thyroid
nodule particularly where irregular solid elements are
identified. In cases where medullary thyroid carcinoma is
suspected on FNAC, patients may proceed directly to total
thyroidectomy and selective lymph node dissection (29).
Conversely, lymph node involvement is less often
encountered in synovial sarcoma, which has a tendency
towards haematogenous spread (30). One should avoid
selective lymph node dissection in these cases unless
imaging raises suspicion. 
It is important for clinicians who encounter thyroid
problems to be aware of this tumour type and its ability to
present rarely in the thyroid gland. Early identification is
essential to facilitate appropriate referral to a dedicated
sarcoma centre. Dedicated follow-up is required to monitor
for local and distant recurrence, which is completely different
from the thyroid cancer follow-up pathway. Surgical resection
remains the mainstay of management for localized synovial
sarcoma with or without radiation (2). Some retrospective
studies have reported an improvement in local control and
disease-free survival conferred by radiotherapy (31-33),
which may be administered in the pre-operative or post-
operative setting. In five of the previously reported thyroid
cases, complete excision of the primary tumour was not
possible at initial operation (5, 6, 7, 12, 13). In such cases it
is especially pertinent to establish the diagnosis in order to
plan appropriate adjuvant treatment. Four out of five patients
in our series developed metastatic disease suggesting that
synovial sarcoma affecting the thyroid gland has an
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aggressive clinical course. In two of those the interval
between primary diagnosis and metastatic disease was more
than five years. Although the disease is typically aggressive
in its course, late metastases may occur, as illustrated by its
course in our patients. Both patients referred to our institution
for further management and were treated with the
combination of doxorubicin and ifosfamide. These patients
responded to chemotherapy again consistent with a diagnosis
of synovial sarcoma arising at other primary sites. 
In summary, we described our institutional experience of
synovial sarcoma arising in the exceptionally rare location
of the thyroid gland. The rarity of the diagnosis can lead to
difficulty in establishing the correct diagnosis and
determining the appropriate treatment pathway, as has been
observed in our experience. While the pathological features
of primary synovial sarcoma of the thyroid gland are similar
to synovial sarcoma arising at other primary sites, the rarity
of the tumor at this location may lead to pathological
misdiagnoses. Furthermore, there is an evident need of
centralised and individualised treatment in a facility with
both expertise in sarcoma and local treatment of head and
neck tumours in order to optimise the chance of cure and
prevent unnecessary late effects of treatment. Finally, it is
important to realise that metastatic spread may occur years
after the primary diagnosis.
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